Developmental Activation of the AHR Increases Effector CD4+ T Cells and Exacerbates Symptoms in Autoimmune Disease-Prone Gnaq+/- Mice.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 26363170)

Published in Toxicol Sci on September 11, 2015

Authors

Lisbeth A Boule1, Catherine G Burke1, Bruce M Fenton2, Kelly Thevenet-Morrison3, Todd A Jusko4, B Paige Lawrence5

Author Affiliations

1: *Department of Microbiology and Immunology.
2: Department of Radiation Oncology.
3: Department of Public Health Sciences, and.
4: Department of Public Health Sciences, and Department of Environmental Medicine, University of Rochester Medical Center, Rochester, New York.
5: *Department of Microbiology and Immunology, Department of Environmental Medicine, University of Rochester Medical Center, Rochester, New York paige_lawrence@urmc.rochester.edu.

Articles cited by this

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev (2006) 10.24

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature (2008) 9.32

Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol (1989) 8.02

The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol (2007) 3.68

Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol (2009) 3.13

Sex differences in autoimmune disease from a pathological perspective. Am J Pathol (2008) 1.94

Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol Rev (2013) 1.89

Impaired motor coordination and persistent multiple climbing fiber innervation of cerebellar Purkinje cells in mice lacking Galphaq. Proc Natl Acad Sci U S A (1997) 1.62

Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury. Circulation (2009) 1.56

Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes. Immunotherapy (2009) 1.53

Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun (2011) 1.48

Aryl hydrocarbon receptor control of adaptive immunity. Pharmacol Rev (2013) 1.38

Environmental and gene-environment interactions and risk of rheumatoid arthritis. Rheum Dis Clin North Am (2012) 1.26

Suppression of cellular immunity in rats and mice by maternal treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Int Arch Allergy Appl Immunol (1974) 1.22

T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine (2014) 1.21

Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of Fas ligand in thymic stromal cells and consequent apoptosis in T cells. J Immunol (2005) 1.21

Environmental toxicants and the developing immune system: a missing link in the global battle against infectious disease? Reprod Toxicol (2010) 1.10

"Default" generation of neonatal regulatory T cells. J Immunol (2010) 1.10

The aryl hydrocarbon receptor affects distinct tissue compartments during ontogeny of the immune system. Toxicol Sci (2007) 1.08

Impairment of thymus-dependent immune functions by exposure of the developing immune system to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J Toxicol Environ Health (1977) 1.06

Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol (2007) 1.06

Prenatal PCB exposure and thymus size at birth in neonates in Eastern Slovakia. Environ Health Perspect (2008) 1.02

Pre- and postnatal polychlorinated biphenyl concentrations and longitudinal measures of thymus volume in infants. Environ Health Perspect (2012) 1.01

Immune complex-mediated tissue injury: a multistep paradigm. Trends Immunol (2005) 0.99

Environmental exposures, epigenetic changes and the risk of lupus. Lupus (2014) 0.99

Developmental exposure to the potent aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin Impairs the cell-mediated immune response to infection with influenza a virus, but enhances elements of innate immunity. J Immunotoxicol (2004) 0.98

Power Doppler ultrasound phenotyping of expanding versus collapsed popliteal lymph nodes in murine inflammatory arthritis. PLoS One (2013) 0.95

Expression of T lymphocyte adhesion molecules: regulation during antigen-induced T cell activation and differentiation. Crit Rev Immunol (1998) 0.92

Effects of developmental activation of the AhR on CD4+ T-cell responses to influenza virus infection in adult mice. Environ Health Perspect (2014) 0.92

Geoepidemiology, gender and autoimmune disease. Autoimmun Rev (2011) 0.92

Molecular and cellular mechanisms of T cell development. Cell Mol Life Sci (2004) 0.92

Altered thymic activity in early life: how does it affect the immune system in young adults? Curr Opin Immunol (2011) 0.91

An enhanced postnatal autoimmune profile in 24 week-old C57BL/6 mice developmentally exposed to TCDD. Toxicol Appl Pharmacol (2008) 0.91

Neonatal exposure to low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin causes autoimmunity due to the disruption of T cell tolerance. J Immunol (2009) 0.91

Expert panel workshop consensus statement on the role of the environment in the development of autoimmune disease. Int J Mol Sci (2014) 0.91

G alpha q-containing G proteins regulate B cell selection and survival and are required to prevent B cell-dependent autoimmunity. J Exp Med (2010) 0.89

Unbalanced Neonatal CD4(+) T-Cell Immunity. Front Immunol (2014) 0.87

3,3',4,4'-Tetrachlorobiphenyl inhibits proliferation of immature thymocytes in fetal thymus organ culture. Scand J Immunol (1994) 0.86

The deficiency of Gαq leads to enhanced T-cell survival. Immunol Cell Biol (2014) 0.85

Perinatal TCDD exposure and the adult onset of autoimmune disease. J Immunotoxicol (2008) 0.84

Identification of stage-specific gene modulation during early thymocyte development by whole-genome profiling analysis after aryl hydrocarbon receptor activation. Mol Pharmacol (2010) 0.83

The effect of perinatal exposure to tetrachlorodibenzo-p-dioxin on the immune response of young mice. Drug Chem Toxicol (1979) 0.83

Differential immunotoxicity induced by two different windows of developmental trichloroethylene exposure. Autoimmune Dis (2014) 0.82

Gene-environment interaction in autoimmune disease. Expert Rev Mol Med (2014) 0.82

Linking the aryl hydrocarbon receptor with altered DNA methylation patterns and developmentally induced aberrant antiviral CD8+ T cell responses. J Immunol (2015) 0.82

Gαq controls rheumatoid arthritis via regulation of Th17 differentiation. Immunol Cell Biol (2015) 0.81

Prenatal TCDD in mice increases adult autoimmunity. Reprod Toxicol (2010) 0.80

Validation of 3-dimensional ultrasound versus magnetic resonance imaging quantification of popliteal lymph node volume as a biomarker of erosive inflammatory arthritis in mice. Arthritis Rheum (2012) 0.80

A single mid-gestation exposure to TCDD yields a postnatal autoimmune signature, differing by sex, in early geriatric C57BL/6 mice. Toxicology (2011) 0.80

Proliferation inhibition and CD4/CD8 thymocyte subset skewing by in vivo exposure of C57BL/6 mice to Ah receptor-binding 3,3',4,4'-tetrachlorobiphenyl. Exp Clin Immunogenet (1994) 0.79

Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway. Int Immunopharmacol (2005) 0.79

Prenatal TCDD causes persistent modulation of the postnatal immune response, and exacerbates inflammatory disease, in 36-week-old lupus-like autoimmune SNF1 mice. Birth Defects Res B Dev Reprod Toxicol (2011) 0.79

Activation of the aryl hydrocarbon receptor during development enhances the pulmonary CD4+ T-cell response to viral infection. Am J Physiol Lung Cell Mol Physiol (2015) 0.77

Associations Between Selected Xenobiotics and Antinuclear Antibodies in the National Health and Nutrition Examination Survey, 1999-2004. Environ Health Perspect (2015) 0.76